Fresenius recalls drug vials due to glass specs
Jul. 02, 2013
WASHINGTON (AP) — The American unit of German drugmaker Fresenius is recalling four lots of an injectable drug after finding particles of glass in some vials of the medication.
The recall applies to four lots of benztropine mesylate injection, which is used to treat Parkinson's disease and some movement side effects related to epilepsy drugs. The drug is manufactured by Allergy Laboratories Inc. and distributed by Fresenius Kabi. The products may also appear with APP or Nexus Pharmaceuticals listed as the manufacturer on the label.
Fresenius Kabi USA says no adverse reactions or customer complaints have been reported.
The company is asking health care professionals to return the products.
On the Web: www.apppharma.com/our-products/product-updates3